ALL YOU NEED TO KNOW ABOUT
HEXVIX 85 MG
(HEXYLAMINOLEVULINATE AS HYDROCHLORIDE 85 MG)
Better diagnose
- Daneshmand, S. et al. Efficacy and safety of blue light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: a phase III, comparative multicenter study. J. Urol. 199, 1158–1165 (2018).
- Burger, M. et al. Photodynamic diagnosis of nonmuscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta- analysis of detection and recurrence based on raw data. Eur. Urol. 64, 846–854 (2013).
Reduce recurrence rate
- Grossman, H. B. et al. Long- term reduction in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy. J. Urol. 188, 58–62 (2012).
- Mariappan, P., Rai, B. & El- Mokadem, I. Real- life experience: early recurrence wtih Hexvix photodynamic diagnosis- assisted transurethral resection of bladder tumour versus good- quality white light TURBT in new non- muscle-invasive bladder cancer. Urology 86, 327–331 (2015).
Reduce progression
Outpatient setting (US phase 3 study)
Cochrane data base-reduce recurrence and progression rate
Guideline
European Association of Urology-2014
USA-review of the clinical evidence and consensus statement on optimal use in the USA — update 2018
AUA/SUO Guideline
Techniques & Maneuvers for Optimal TURBT w/ Dr. Sam Chang | BackTable Urology Podcast Ep. 46
Dr. Aditya Bagrodia interviews Dr. Sam Chang, chief of urologic oncology at Vanderbilt University, about surgical tips and tricks for intermediate and high risk bladder cancer.
Blue Light Cystoscopy: Who, When, and How?
Dr. Anne Schuckman Dr. Aditya Bagrodia speaks with urologist Dr. Anne Schuckman from the University of Southern California about advantages and advice for blue light cystoscopy, a procedure performed to identify bladder tumors during transurethral resection of bladder tumor (TURBT).
Coming Soon
Approved 12/2022
Click Here For More Information